1. Oct4, Oct1, and Cancer Stem Cells
   Jessica Maddox et al, 2014, Cancer Stem Cells CrossRef
2. Advances and perspectives of colorectal cancer stem cell vaccine
   Mei Guo et al, 2015, Biomedicine & Pharmacotherapy CrossRef
3. Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients
   Raheleh Roudi et al, 2020, Molecular & Cellular Oncology CrossRef
4. Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage: Mechanisms and clinical implications
   Guanglin Cui et al, 2022, Frontiers in Immunology CrossRef
5. Stemness-Related Transcriptional Factors and Homing Gene Expression Profiles in Hepatic Differentiation and Cancer
   Eman A Toraih et al, 2016, Molecular Medicine CrossRef
6. Down-regulation of anti-apoptotic genes in tumor cell lines is facilitated by suppression of OCT4B1
   Mohammad Reza Mirzaei et al, 2017, Advances in Medical Sciences CrossRef
7. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma
   Mai Iwaya et al, 2021, BMC Cancer CrossRef
8. Expression of OCT4A: The First Step to the Next Stage of Urothelial Bladder Cancer Progression
   Wojciech Jóźwicki et al, 2014, International Journal of Molecular Sciences CrossRef
9. Potential Role of OCT4 in Leukemogenesis
   Tiphanie Picot et al, 2017, Stem Cells and Development CrossRef
10. OCT4 Represses Inflammation and Cell Injury During Orchitis by Regulating CIP2A Expression
    Ruifeng Zeng et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
11. ZNF281/ZBP-99: a new player in epithelial–mesenchymal transition, stemness, and cancer
    Stefanie Hahn et al, 2014, Journal of Molecular Medicine CrossRef
12. Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway
    HAI LIN et al, 2014, Molecular Medicine Reports CrossRef
13. Genetic Determinants Associated With Early Age of Diagnosis of IBD
    Tara M. Connelly et al, 2015, Diseases of the Colon & Rectum CrossRef
14. Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer
    Davide Brocco et al, 2022, Cancers CrossRef
15. Inflammatory Bowel Disease: Pathobiology
    Tara M. Connelly et al, 2016, The ASCRS Textbook of Colon and Rectal Surgery CrossRef
16. Differential expression of two genes Oct‐4 and MUC5AC associates with poor outcome in patients with gastric cancer
    Milad Javanbakht et al, 2017, Clinical and Experimental Pharmacology and Physiology CrossRef
17. Inflammatory bowel disease and carcinogenesis
    Hiroko Nagao-Kitamoto et al, 2022, Cancer and Metastasis Reviews CrossRef
18. Oct4 reduction contributes to testicular injury of unilateral testicular torsion in mice model and apoptotic death of Sertoli cells through mediating CIP2A expression
    Haochuan Zhang et al, 2023, Gene CrossRef
19. Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer
    Jingjing Liu et al, 2023, International Journal of Molecular Sciences CrossRef
20. Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug
    Chun Sun et al, 2013, Medical Oncology CrossRef
21. Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis
    Ferenc Sipos, 2015, World Journal of Gastroenterology CrossRef